Life Sciences

Flag eligible populations for clinical trials. Identify cohorts for therapeutic efforts.

EarlySign’s machine learning solutions identify patients at-risk for high burden disease and create opportunities for timely intervention.

As a leading provider of machine-learning solutions for the healthcare community, EarlySign’s flexible solutions support life science organizations in their quest to:

  • Flag eligible populations for Clinical Trial development
  • Identify cohorts for therapeutic efforts
  • Work with clinical partners and providers for early intervention opportunities
  • Create platforms for informed discussion with healthcare professionals about screening

EarlySign’s machine learning solutions identify patients at-risk for high-burden diseases and create opportunities for timely intervention.

The result: Condition-specific, personalized clinical models with the potential for more robust findings and lower downstream care costs.
  • Our validated clinical solutions help identify members at high probability for progressing to high-burden diseases and related complications. This creates opportunities for timely intervention to help prevent or delay diseases like:
  • Diabetes
  • Cardiovascular Disease
  • Kidney Disease
  • Flu Complications
  • Lower GI Disorders

Are you looking to solve high-burden disease challenges?